TL

Thierry Laugel

Managing Partner at Kurma Partners

Paris, Île-de-France

Investor
VC

Invests in

Locations:

Paris, France

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Biotechnology
Venture Capital
Lifesciences
Technology Transfer
Pharmaceutical Industry
Commercialization
Life Sciences
Start-ups
Due Diligence
Corporate Development
Drug Development
Entrepreneurship
Biopharmaceuticals
Private Equity
Strategy
Clinical Development
Business Strategy
Medical Devices
R&D
Mergers & Acquisitions

Education

Investments

Corteria Pharmaceuticals

Seed

Total Funding: $84M

Amolyt Pharma

Series A

Total Funding: $290M

Ermium Therapeutics

Series A

Total Funding: $6M

Emergence Therapeutics

Series A

Total Funding: $98M

Coave Therapeutics

Series B

Total Funding: $22M

Minoryx Therapeutics

Series A

Total Funding: $81M

Work Experience

Kurma Partners

2009

  • Managing Partner

    2009

    Founder and Managing Partner of Kurma Partners ; management of 700 ME of private equity funds in Healthcare from BioPharma to digital health in creation, venture and growth capital.

AGF Private Equity (Allianz Group)

2006 - 2009

  • Partner

    2006 - 2009

    In charge of the development of the Healthcare practice (approx. 80ME invested ; cash to cash return of approx 20% IRR)

CDC Innovation

1998 - 2005

  • Partner Healthcare

    1998 - 2005

    In charge of investments in European Biotech / Healthcare companies - 40 ME invested - cash to cash return > 20% IRR

Flamel

1996 - 1998

  • Portfolio Director

    1996 - 1998

    In charge of the R&D portfolio management

Fournier Japan

1992 - 1996

  • R&D Manager -Liaison Officer

    1992 - 1996

    Coordination of R&D programs in Japan